Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanvi V Chiddarwar

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2025
Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United StatesTanvi V Chiddarwar, Hawre Jalal, Fernando Alarid-Escudero, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 11, 2025
Long-term Trends in Bladder Cancer Incidence Using a Harmonized Staging Variable: A SEER-Based StudyPraveen Kumar, Jennifer Ruhl, Tanvi V Chiddarwar, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Differences in Bladder Cancer Diagnosis by Demographic Factors: A Simulation Modeling AnalysisPraveen Kumar, Fernando Alarid-Escudero, Tanvi V Chiddarwar, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2025
Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United StatesTanvi V Chiddarwar, Hawre Jalal, Fernando Alarid-Escudero, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 11, 2025
Long-term Trends in Bladder Cancer Incidence Using a Harmonized Staging Variable: A SEER-Based StudyPraveen Kumar, Jennifer Ruhl, Tanvi V Chiddarwar, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Differences in Bladder Cancer Diagnosis by Demographic Factors: A Simulation Modeling AnalysisPraveen Kumar, Fernando Alarid-Escudero, Tanvi V Chiddarwar, et al.
Pageof 1